Literature DB >> 8798505

Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells.

J Sutton1, R Costa, M Klug, L Field, D Xu, D A Largaespada, C F Fletcher, N A Jenkins, N G Copeland, M Klemsz, R Hromas.   

Abstract

A novel member of the winged helix (formerly HNF-3/Forkhead) transcriptional regulatory family, termed Genesis, was isolated and characterized. Putative translation of the complete cDNA revealed the winged helix DNA binding domain to be centrally located within the protein, with regions on either side that contain known transcriptional regulatory motifs. Extensive Northern analysis of Genesis found that the message was exclusively expressed in embryonic stem cells or their malignant equivalent, embryonal carcinoma cells. The Genesis transcript was down-regulated when these cells were stimulated to differentiate. DNA sequences that Genesis protein would interact with were characterized and were found to contain a consensus similar to that found in an embryonic stem cell enhancer sequence. Co-transfection experiments revealed that Genesis is a transcriptional repressor. Genesis mapped to mouse chromosome 4 in a region syntenic with human chromosome 1p31, a site of nonrandom abnormalities in germ cell neoplasia, neuroblastoma, and acute lymphoblastic leukemia. Genesis is a candidate for regulating the phenotype of normal or malignant embryonic stem cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798505     DOI: 10.1074/jbc.271.38.23126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.

Authors:  D J Garry; A Meeson; J Elterman; Y Zhao; P Yang; R Bassel-Duby; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo.

Authors:  Lynn A Hanna; Ruth K Foreman; Illya A Tarasenko; Daniel S Kessler; Patricia A Labosky
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

4.  Transient expression of a winged-helix protein, MNF-beta, during myogenesis.

Authors:  Q Yang; R Bassel-Duby; R S Williams
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 5.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

6.  FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

Authors:  Ethan V Abel; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

7.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.

Authors:  Jamie M Sperger; Xin Chen; Jonathan S Draper; Jessica E Antosiewicz; Chris H Chon; Sunita B Jones; James D Brooks; Peter W Andrews; Patrick O Brown; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

8.  Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.

Authors:  Hua Zhao; Daozhen Chen; Jiayuan Wang; Yongxiang Yin; Qiong Gao; Ye Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  A novel FoxD3 gene trap line reveals neural crest precursor movement and a role for FoxD3 in their specification.

Authors:  Tatiana Hochgreb-Hägele; Marianne E Bronner
Journal:  Dev Biol       Date:  2012-12-08       Impact factor: 3.582

Review 10.  Epigenetic alterations in a murine model for chronic lymphocytic leukemia.

Authors:  Shih-Shih Chen; Mara H Sherman; Erin Hertlein; Amy J Johnson; Michael A Teitell; John C Byrd; Christoph Plass
Journal:  Cell Cycle       Date:  2009-11-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.